Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.
Moll M, Magrowski Ł, Mittlböck M, Heinzl H, Kirisits C, Ciepał J, Masri O, Heilemann G, Stando R, Krzysztofiak T, Depowska G, d'Amico A, Techmański T, Kozub A, Majewski W, Suwiński R, Wojcieszek P, Sadowski J, Widder J, Goldner G, Miszczyk M.
Moll M, et al. Among authors: suwinski r.
Strahlenther Onkol. 2024 Jun 3. doi: 10.1007/s00066-024-02245-3. Online ahead of print.
Strahlenther Onkol. 2024.
PMID: 38829436